| |
Our portfolio
Our
portfolio | Investment Guidelines |
Valuation Guidelines
|
Performance of ProgressNow!
|
as
per 12.03.2010
|
| Share price (SWX Swiss
Exchange) |
CHF 8.89 |
| Performance since 1.1.2010 |
-4.4% |
| Net Asset Value (preliminary unaudited
figure) |
CHF 19.25 |
|
Portfolio
|
as per 12.03.2010 |
| Company |
Amount |
Historical
price |
Current
valuation
per share |
+ / - |
Fair value
(in CHF) |
% of
portfolio |
| Cadent Holdings, Inc | 336'372 | USD 5.92 | USD 4.29 | -27.5% | 1'527'797.54 | 12.4% | | Cadent warrants | 637 | USD 0.00 | USD 3.97 | 0.0% | 2'677.60 | 0.0% | | Enablearning, Inc | 1'452'905 | USD 0.87 | USD 0.00 | -100.0% | 0.00 | 0.0% | | Hansen Medical, Inc | 63'011 | USD 5.60 | USD 2.42 | -56.8% | 161'315.60 | 1.3% | | Oceanlinx Ltd | 348'179 | AUD 2.00 | AUD 0.35 | -82.5% | 117'999.60 | 1.0% | | Velico Medical, Inc | 9'906'585 | USD 0.92 | USD 1.00 | 8.8% | 10'480'176.27 | 85.3% |
|
Total (in CHF)
|
12'289'966.62 |
100.0% |
Exchange rate in CHF | | USD | 1.0579 | | AUD | 0.9683 | | GBP | 1.6065 |
|
|
